ey0016.9-2 | Metabolic and Cardiovascular Risk in Cancer Survivors | ESPEYB16
D D'Souza , S Roubos , J Larkin , J Lloyd , R Emmons , H Chen , M De Lisio
ey0016.11-8 | Metabolic Signaling | ESPEYB16
C Crewe , N Joffin , JM Rutkowski , M Kim , F Zhang , DA Towler , R Gordillo , PE Scherer
ey0016.13-3 | Diabetes | ESPEYB16
GD Ogle , JE von Oettingen , AC Middlehurst , R Hanas , TJ Orchard
ey0016.13-12 | Growth and Nutrition | ESPEYB16
ND Ford , JR Behrman , JF Hoddinott , JA Maluccio , R Martorell , M Ramirez-Zea , AD Stein
ey0016.14-10 | (1) | ESPEYB16
KK Yusuf , HM Salihu , R Wilson , A Mbah , W Sappenfield , LM King , K Bruder
ey0015.1-5 | New mechanisms | ESPEYB15
L Cheung , P Le Tissier , SG Goldsmith , M Treier , R Lovell-Badge , K Rizzoti
ey0015.9-2 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
L Collins , L Beaumont , A Cranston , S Savoie , T Nayiager , R Barr
ey0015.9-13 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15
L Haas , R Chevalier , BT Major , F Enders , S Kumar , J Tung
ey0015.11-2 | New insight into obesity comorbidities | ESPEYB15
G Zabarsky , C Beek , E Hagman , B Pierpoint , S Caprio , R Weiss
ey0015.13-7 | How does paediatric endocrinology and diabetes fit in the global initiatives? | ESPEYB15
S Horton , R Sullivan , J Flanigan , KA Fleming , MA Kuti , LM Looi , SA Pai , M Lawler